Alternative bevacizumab schedule in high-grade gliomas recurrence is associated with reductions in greenhouse gas emissions without loss of clinical efficacy. - Lego J; Larroquette M; Pedebosc S; Chanjour JL; Digue L; Huchet A; Jecko V; Engelhardt J; Bronnimann C (Cancer treatment and research communications, 2026)